GSK is acquiring 35Pharma for $950 million, and getting rights to HS235, a potential best-in-class PH treatment now in early clinical testing.
Columnist Jolie Lizana says that an IV pump saved her life, but she's also grateful to have transitioned off it to oral ...
The Heart Works app, from advocacy group Phaware, offers health tracking, AI support, and research tools for the global PH ...
A trial testing seralutinib for pulmonary arterial hypertension narrowly missed its main goal, but benefits were seen among ...
Columnist Anna Jeter explains that her mom, who is her primary caregiver, has rarely traveled since Anna's 1999 PH diagnosis. That changed.
Columnist Jen Cueva has been reflecting a lot lately on AI and healthcare, as she's experienced it personally during appointments.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results